Acas, LLC Pfizer Inc Transaction History

Acas, LLC

$101 Million
Q1 2024

A detailed history of Acas, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Acas, LLC holds 14,987 shares of PFE stock, worth $419,336. This represents 0.41% of its overall portfolio holdings.

Number of Shares

14,987

Previous 15,694 4.5%

Holding current value

$419,336

Previous $451,000 7.98%

% of portfolio

0.41%

Previous 0.52%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $18,304 - $21,019	-707 Reduced 4.5%	14,987 $415,000
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $25,084 - $32,582	-960 Reduced 5.76%	15,694 $451,000
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $6,097 - $7,126	-190 Reduced 1.13%	16,654 $552,000
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $5,779 - $6,686	-160 Reduced 0.94%	16,844 $617,000
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $84,530 - $110,046	2,146 Added 14.44%	17,004 $693,000

Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $1,163 - $1,379	-25 Reduced 0.17%	14,858 $750,000
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $183,000 - $226,760	-4,000 Reduced 21.18%	14,883 $770,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $780,245 - $1.16 Million	18,883 New	18,883 $1.09 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $617,031 - $914,646	-14,933 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $24,374 - $31,310	-621 Reduced 3.99%	14,933 $642,000
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $136,996 - $155,194	-3,815 Reduced 19.7%	15,554 $609,000
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $648,667 - $731,567	19,369 New	19,369 $576,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acas, LLC with notifications on news.

Account